Molecular factors influence relapse patterns in glioblastoma. The hotspot mutation located at position 289 of the extracellular domain of the epidermal growth factor receptor (EGFRAn ancillary study from a prospective cohort of patients suffering from glioblastoma was conducted. All patients received radiotherapy and concomitant temozolomide. The population was divided into two groups according to EGFROne hundred twenty-eight patients were included and analyzed: 11% had EGFRWe highlighted a link between the EGFR
Full Text via ClinicalKey